Publikationen in Zusammenarbeit mit Forschern von Hospital de São João (35)

2020

  1. Pitfalls in Challenging Thyroid Tumors: Emphasis on Differential Diagnosis and Ancillary Biomarkers

    Endocrine Pathology, Vol. 31, Núm. 3, pp. 197-217

  2. Tumors of the thyroid gland. Proposal for the management and study of samples from patients with thyroid neoplasms

    Revista Espanola de Patologia, Vol. 53, Núm. 1, pp. 27-36

2018

  1. Cribriform-morular variant of thyroid carcinoma: a neoplasm with distinctive phenotype associated with the activation of the WNT/β-catenin pathway

    Modern Pathology, Vol. 31, Núm. 8, pp. 1168-1179

  2. New WHO classification of thyroid tumors: a pragmatic categorization of thyroid gland neoplasms

    Endocrinologia, Diabetes y Nutricion, Vol. 65, Núm. 3, pp. 133-135

2017

  1. EWSR1 rearrangement is a frequent event in papillary thyroid carcinoma and in carcinoma of the thyroid with Ewing family tumor elements (CEFTE)

    Virchows Archiv, Vol. 470, Núm. 5, pp. 517-525

  2. Hobnail variant of papillary thyroid carcinoma: Clinicopathologic and molecular evidence of progression to undifferentiated carcinoma in 2 cases

    American Journal of Surgical Pathology, Vol. 41, Núm. 6, pp. 854-860

  3. Other rare tumours and tumour-like lesions

    Rare Tumors of the Thyroid Gland: Diagnosis and WHO Classification (Springer International Publishing), pp. 79-105

  4. Rare familial tumours

    Rare Tumors of the Thyroid Gland: Diagnosis and WHO Classification (Springer International Publishing), pp. 57-77

  5. Rare follicular tumours

    Rare Tumors of the Thyroid Gland: Diagnosis and WHO Classification (Springer International Publishing), pp. 27-44

  6. Rare papillary thyroid carcinomas

    Rare Tumors of the Thyroid Gland: Diagnosis and WHO Classification (Springer International Publishing), pp. 5-25

  7. Small cell tumours

    Rare Tumors of the Thyroid Gland: Diagnosis and WHO Classification (Springer International Publishing), pp. 45-56

  8. TERT, BRAF, and NRAS in primary thyroid cancer and metastatic disease

    Journal of Clinical Endocrinology and Metabolism, Vol. 102, Núm. 6, pp. 1898-1907

  9. Therapeutic options

    Rare Tumors of the Thyroid Gland: Diagnosis and WHO Classification (Springer International Publishing), pp. 107-110

2016

  1. Genetic predictors of thyroid cancer outcome

    European Journal of Endocrinology, Vol. 174, Núm. 4, pp. R117-R126

2014

  1. C-cell-derived calcitonin-free neuroendocrine carcinoma of the thyroid: The diagnostic importance of cgrp immunoreactivity

    International Journal of Surgical Pathology, Vol. 22, Núm. 6, pp. 530-535

  2. Carcinoma of the thyroid with Ewing/PNET family tumor elements: A tumor of unknown histogenesis

    International Journal of Surgical Pathology

  3. Small cell tumors of the thyroid gland: A review

    International Journal of Surgical Pathology, Vol. 22, Núm. 3, pp. 197-201

  4. TERT promoter mutations are a major indicator of poor outcome in differentiated thyroid carcinomas

    Journal of Clinical Endocrinology and Metabolism, Vol. 99, Núm. 5

2013

  1. Frequency of TERT promoter mutations in human cancers

    Nature Communications, Vol. 4

2012

  1. Absence of the BRAF and the GRIM-19 mutations in oncocytic (hürthle cell) solid cell nests of the thyroid

    American Journal of Clinical Pathology, Vol. 137, Núm. 4, pp. 612-618